CYFIP2 (Homo sapiens) in pDONR221 (Gateway donor/master vector)

Explanation of Terms

Gene:
Gene Symbol:  CYFIP2
Gene Name:  cytoplasmic FMR1 interacting protein 2
Original Clone ID:
FLH195938.01X
Keyword:
None
Species:
Homo sapiens
Type:
cDNA
Vector Name:
pDONR221
Format: 
CLOSED
Source:
HIP
Description:
None
Comments:
None
Mutation / Discrepancy:
No / No
Publications:
None
Authors:
HIP
HsCD00045545
Price: 
Login for Pricing
AVAILABLE
No restriction
Special MTA: None
Insert sequence: 3762nts
Open reading frame: 1 to 3762

ATGACCACGCACGTCACCCTGGAAGATGCCCTGTCCAACGTGGACCTGCTTGAAGAGCTT
CCCCTCCCCGACCAGCAGCCATGCATCGAGCCTCCACCTTCCTCCATCATGTACCAGGCT
AACTTTGACACAAACTTTGAGGACAGGAATGCATTTGTCACGGGCATTGCAAGGTACATT
GAGCAGGCTACAGTCCACTCCAGCATGAATGAGATGCTGGAGGAAGGACATGAGTATGCG
GTCATGCTGTACACCTGGCGCAGCTGTTCCCGGGCCATTCCCCAGGTGAAATGCAACGAG
CAGCCCAACCGAGTAGAGATCTATGAGAAGACAGTAGAGGTGCTGGAGCCGGAGGTCACC
AAGCTCATGAAGTTCATGTATTTTCAGCGCAAGGCCATCGAGCGGTTCTGCAGCGAGGTG
AAGCGGCTGTGCCATGCCGAGCGCAGGAAGGACTTTGTCTCTGAGGCCTACCTCCTGACC
CTTGGCAAGTTCATCAACATGTTTGCTGTCCTGGATGAGCTAAAGAACATGAAGTGCAGC
GTCAAGAATGACCACTCTGCCTACAAGAGGGCAGCACAGTTCCTGCGGAAGATGGCAGAT
CCCCAGTCTATCCAGGAGTCGCAGAACCTTTCCATGTTCCTGGCCAACCACAACAGGATC
ACCCAGTGTCTCCACCAGCAACTTGAAGTGATCCCAGGCTATGAGGAGCTGCTGGCTGAC
ATTGTCAACATCTGTGTGGATTACTACGAGAACAAGATGTACCTGACTCCCAGTGAGAAA
CATATGCTCCTCAAGGTGATGGGCTTTGGCCTCTACCTAATGGATGGAAATGTCAGTAAC
ATTTACAAACTGGATGCCAAGAAGAGAATTAATCTTAGCAAAATTGATAAATTCTTTAAG
CAGCTGCAGGTGGTGCCCCTTTTCGGCGACATGCAGATAGAGCTGGCCAGATACATTAAG
ACCAGTGCTCACTATGAAGAGAACAAGTCCAAGTGGACGTGCACCCAGAGCAGCATCAGC
CCCCAGTACAATATCTGCGAGCAGATGGTTCAGATCCGGGATGACCACATCCGCTTCATC
TCCGAGCTCGCTCGCTACAGCAACAGTGAGGTGGTGACGGGCTCAGGGCTGGACAGCCAG
AAGTCAGACGAGGAGTATCGCGAGCTCTTCGACCTAGCCCTGCGGGGTCTGCAGCTTCTA
TCCAAGTGGAGCGCCCACGTCATGGAGGTGTACTCTTGGAAGCTGGTTCATCCCACAGAC
AAGTTCTGCAACAAGGACTGTCCTGGCACCGCGGAGGAATATGAGAGAGCCACACGCTAC
AATTACACCAGTGAGGAAAAATTTGCCTTCGTTGAGGTGATCGCCATGATCAAAGGCCTG
CAGGTGCTCATGGGCAGGATGGAGAGCGTCTTCAACCAGGCCATCAGGAACACCATCTAC
GCGGCATTGCAGGACTTCGCCCAGGTGACGCTGCGTGAGCCCCTGCGGCAGGCGGTACGG
AAGAAGAAGAATGTCCTCATCAGCGTCCTACAGGCAATTCGAAAGACCATCTGTGACTGG
GAGGGAGGGCGAGAGCCCCCTAATGACCCATGCTTGAGAGGGGAGAAGGACCCCAAAGGT
GGATTTGATATCAAGGTGCCCCGGCGTGCTGTGGGGCCATCCAGCACACAGCTGTACATG
GTGCGGACCATGCTTGAATCACTCATTGCAGACAAAAGCGGCTCCAAGAAGACCCTGAGG
AGCAGCCTGGATGGACCCATTGTCCTCGCCATAGAGGACTTTCACAAACAGTCCTTCTTC
TTCACACATCTGCTCAACATCAGTGAAGCCCTGCAGCAGTGTTGTGACCTCTCCCAGCTC
TGGTTCCGAGAATTCTTCCTGGAGTTAACCATGGGCCGACGAATCCAGTTCCCCATCGAG
ATGTCCATGCCCTGGATTCTAACGGACCATATCCTGGAAACCAAAGAACCTTCCATGATG
GAGTATGTCCTCTACCCTCTGGATCTGTACAACGACAGCGCCTACTATGCTCTGACCAAG
TTTAAAAAGCAGTTCCTGTACGATGAGATAGAAGCTGAGGTGAACCTGTGTTTTGATCAG
TTTGTCTACAAGCTGGCAGACCAGATCTTTGCTTACTACAAAGCCATGGCTGGCAGTGTC
CTGTTGGATAAACGTTTTCGAGCTGAGTGTAAGAATTATGGCGTCATCATTCCGTATCCA
CCGTCCAATCGCTATGAAACACTGCTGAAGCAGAGACACGTCCAGCTGTTGGGTAGATCA
ATTGACTTGAACAGACTCATTACCCAGCGCACCTCTGCCGCCATGTATAAATCCTTGGAC
CAAGCTATCAGCCGCTTTGAGAGTGAGGACCTGACCTCCATTGTGGAGCTGGAGTGGCTG
CTGGAGATTAACCGGCTCACGCATCGGCTGCTCTGTAAGCATATGACGCTGGACAGCTTC
GATGCCATGTTCCGAGAGGCCAATCACAATGTGTCCGCCCCCTATGGCCGTATCACCCTG
CATGTCTTCTGGGAACTGAACTTTGACTTTCTCCCCAACTACTGCTACAATGGGTCCACT
AACCGTTTTGTGCGGACTGCCATTCCTTTCACCCAAGAACCACAACGAGACAAACCTGCC
AACGTCCAGCCTTATTACCTCTATGGATCCAAGCCTCTCAACATTGCCTACAGCCACATC
TACAGCTCCTACAGGAATTTCGTGGGGCCACCTCATTTCAAGACTATCTGCAGACTCCTG
GGTTATCAGGGCATCGCTGTGGTCATGGAGGAACTGCTAAAGATTGTGAAGAGCTTGCTC
CAAGGAACCATTCTCCAGTATGTGAAAACACTGATAGAGGTGATGCCCAAGATATGCCGC
TTGCCCCGACATGAGTATGGCTCCCCAGGGATCCTGGAGTTCTTCCACCACCAGCTGAAG
GACATCATTGAGTACGCAGAGCTCAAAACAGACGTGTTCCAGAGCCTGAGGGAAGTGGGC
AATGCCATCCTCTTCTGCCTCCTCATAGAGCAAGCTCTGTCTCAGGAGGAGGTCTGCGAT
TTGCTCCATGCCGCACCCTTCCAAAACATCTTGCCTAGAGTCTACATCAAAGAGGGGGAG
CGCCTGGAGGTCCGGATGAAACGTCTGGAAGCCAAGTATGCCCCGCTCCACCTGGTCCCT
CTGATCGAGCGGCTGGGGACCCCTCAGCAAATCGCCATTGCTCGCGAGGGTGACCTCCTG
ACCAAGGAGCGGCTGTGCTGTGGCCTGTCCATGTTCGAGGTCATCCTGACCCGCATTCGG
AGCTACCTGCAGGACCCCATCTGGCGGGGCCCACCGCCCACCAATGGCGTCATGCACGTC
GATGAGTGTGTGGAGTTCCACCGGCTGTGGAGCGCCATGCAGTTCGTGTACTGCATCCCT
GTGGGAACCAACGAGTTCACAGCTGAGCAGTGTTTCGGCGATGGCTTGAACTGGGCTGGT
TGCTCCATCATTGTCCTGCTGGGCCAGCAGCGTCGCTTTGACCTGTTCGACTTCTGTTAC
CACCTGCTAAAAGTGCAGAGGCAGGACGGGAAGGATGAAATCATTAAGAATGTGCCCCTG
AAGAAGATGGCCGACCGGATCAGGAAGTATCAGATCTTGAACAATGAGGTTTTTGCCATC
CTGAACAAATACATGAAGTCCGTGGAGACAGACAGTTCCACTGTGGAGCATGTGCGCTGC
TTCCAGCCACCCATCCACCAGTCCTTGGCCACCACTTGCTAG

Protein sequence predicted based on nucleotide sequence

MTTHVTLEDALSNVDLLEELPLPDQQPCIEPPPSSIMYQANFDTNFEDRNAFVTGIARYI
EQATVHSSMNEMLEEGHEYAVMLYTWRSCSRAIPQVKCNEQPNRVEIYEKTVEVLEPEVT
KLMKFMYFQRKAIERFCSEVKRLCHAERRKDFVSEAYLLTLGKFINMFAVLDELKNMKCS
VKNDHSAYKRAAQFLRKMADPQSIQESQNLSMFLANHNRITQCLHQQLEVIPGYEELLAD
IVNICVDYYENKMYLTPSEKHMLLKVMGFGLYLMDGNVSNIYKLDAKKRINLSKIDKFFK
QLQVVPLFGDMQIELARYIKTSAHYEENKSKWTCTQSSISPQYNICEQMVQIRDDHIRFI
SELARYSNSEVVTGSGLDSQKSDEEYRELFDLALRGLQLLSKWSAHVMEVYSWKLVHPTD
KFCNKDCPGTAEEYERATRYNYTSEEKFAFVEVIAMIKGLQVLMGRMESVFNQAIRNTIY
AALQDFAQVTLREPLRQAVRKKKNVLISVLQAIRKTICDWEGGREPPNDPCLRGEKDPKG
GFDIKVPRRAVGPSSTQLYMVRTMLESLIADKSGSKKTLRSSLDGPIVLAIEDFHKQSFF
FTHLLNISEALQQCCDLSQLWFREFFLELTMGRRIQFPIEMSMPWILTDHILETKEPSMM
EYVLYPLDLYNDSAYYALTKFKKQFLYDEIEAEVNLCFDQFVYKLADQIFAYYKAMAGSV
LLDKRFRAECKNYGVIIPYPPSNRYETLLKQRHVQLLGRSIDLNRLITQRTSAAMYKSLD
QAISRFESEDLTSIVELEWLLEINRLTHRLLCKHMTLDSFDAMFREANHNVSAPYGRITL
HVFWELNFDFLPNYCYNGSTNRFVRTAIPFTQEPQRDKPANVQPYYLYGSKPLNIAYSHI
YSSYRNFVGPPHFKTICRLLGYQGIAVVMEELLKIVKSLLQGTILQYVKTLIEVMPKICR
LPRHEYGSPGILEFFHHQLKDIIEYAELKTDVFQSLREVGNAILFCLLIEQALSQEEVCD
LLHAAPFQNILPRVYIKEGERLEVRMKRLEAKYAPLHLVPLIERLGTPQQIAIAREGDLL
TKERLCCGLSMFEVILTRIRSYLQDPIWRGPPPTNGVMHVDECVEFHRLWSAMQFVYCIP
VGTNEFTAEQCFGDGLNWAGCSIIVLLGQQRRFDLFDFCYHLLKVQRQDGKDEIIKNVPL
KKMADRIRKYQILNNEVFAILNKYMKSVETDSSTVEHVRCFQPPIHQSLATTC*

Coding Sequence Details

Insert Sequence Verified?:
Y
Verification Method:
Sequence Verification
Reference Sequence Annotations:
Start on reference sequence 266
End on reference sequence 4027
Mutations:
None
Discrepancy:
None
5' Linker Sequence:
None
3' Linker Sequence:
None

Recommended Growth Condition:

Distributed in bacterial strain:
DH5-alpha T1 phage resistant
Antibiotic Selection:
Host Type:  bacterial    Marker:  kanamycin
Bacterial Selection Condition: 50ug/mL kanamycin
Growth Condition: Growth with the single antibiotic in LB at 37 degrees is recommended.
Comments: Conditions for Gateway-type vectors in recombined (with insert) form and other kanamycin resistant vectors.
Protein Expression Results:
None
Recommended expression in:
Not Applicable